Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, Status and Forecast 2020-2026

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%.

ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.

North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.

Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market
In 2019, the global ICAD (Intracranial Atherosclerotic Disease) Pathology market size was US$ 159.9 million and it is expected to reach US$ 290.5 million by the end of 2026, with a CAGR of 8.8% during 2021-2026.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Scope and Market Size
ICAD (Intracranial Atherosclerotic Disease) Pathology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global ICAD (Intracranial Atherosclerotic Disease) Pathology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the ICAD (Intracranial Atherosclerotic Disease) Pathology market is segmented into primarily split into, Stent, PTA Balloon, etc.
Segment by Application, the ICAD (Intracranial Atherosclerotic Disease) Pathology market is segmented into Hospital, Clinic, Other, etc.
Regional and Country-level Analysis
The ICAD (Intracranial Atherosclerotic Disease) Pathology market is analysed and market size information is provided by regions (countries).
The key regions covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Analysis
ICAD (Intracranial Atherosclerotic Disease) Pathology market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in ICAD (Intracranial Atherosclerotic Disease) Pathology business, the date to enter into the ICAD (Intracranial Atherosclerotic Disease) Pathology market, ICAD (Intracranial Atherosclerotic Disease) Pathology product introduction, recent developments, etc.
The major vendors include Stryker, Balt, TERUMO, MicroPort, Acandis, etc.

This report focuses on the global ICAD (Intracranial Atherosclerotic Disease) Pathology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the ICAD (Intracranial Atherosclerotic Disease) Pathology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Stryker
Balt
TERUMO
MicroPort
Acandis
...

Market segment by Type, the product can be split into

primarily split into
Stent
PTA Balloon

Market segment by Application, split into

Hospital
Clinic
Other

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global ICAD (Intracranial Atherosclerotic Disease) Pathology status, future forecast, growth opportunity, key market and key players.
To present the ICAD (Intracranial Atherosclerotic Disease) Pathology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of ICAD (Intracranial Atherosclerotic Disease) Pathology are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.